Related by context. All words. (Click for frequent words.) 64 endometrial cancers 64 leiomyomas 63 atypical hyperplasia 63 invasive carcinoma 62 paragangliomas 62 renal tumors 62 cell lymphoma ALCL 62 MGUS 62 medullary thyroid cancer 62 mesotheliomas 62 carcinoma 62 HGPIN 62 mucinous 61 anti angiogenic therapy 61 breast carcinoma 61 GISTs 61 nonmelanoma skin cancer 61 pheochromocytoma 61 colorectal cancer CRC 61 basal cell carcinoma BCC 61 ASCUS 61 testicular cancers 60 thromboembolic events 60 endometrial carcinoma 60 urothelial carcinoma 60 neuroendocrine tumors 60 uveal melanoma 60 neoplasms 60 NSF NFD 60 vulvar cancer 60 neoplasia 60 axillary dissection 60 atypical femur fractures 60 atypia 60 prostate cancer CaP 60 malignant pleural mesothelioma 60 operable breast cancer 60 anal cancers 60 thyroid nodules 60 osteosarcomas 60 epithelial ovarian cancer 60 nonmelanoma skin cancers 60 carcinomas 59 carcinoid 59 adenocarcinomas 59 noninfectious uveitis 59 pancreatic adenocarcinoma 59 thromboembolic disease 59 ADPKD 59 nodal metastasis 59 malignancy 59 chlamydial infection 59 cervical dysplasia 59 adenomatous polyps 59 bladder cancers 59 gastric adenocarcinoma 59 micrometastases 59 locoregional recurrence 59 malignancies 59 varicoceles 59 grade cervical intraepithelial 59 endometrial hyperplasia 59 HER2 positive breast cancer 59 prostate adenocarcinoma 59 ductal carcinomas 59 SLNB 59 precancerous cervical lesions 59 incidentalomas 59 tumor histology 59 recurrent ovarian cancer 58 sonographic findings 58 Uterine fibroids 58 PCa 58 atypical subtrochanteric femur fractures 58 hepatocellular carcinoma HCC 58 invasive breast cancer 58 CIN2 + 58 Recurrences 58 oropharyngeal cancer 58 Malignant Melanoma 58 neoadjuvant therapy 58 resistant ovarian cancer 58 indolent NHL 58 malignant neoplasm 58 basal cell carcinomas 58 colorectum 58 breast lesions 58 skeletal metastases 58 neoplastic lesions 58 urothelial cancer 58 bone metastasis 58 penile cancers 58 histopathologic 58 tumor recurrence 58 papillary 58 colorectal liver metastases 58 vertebral compression fractures 58 PCNSL 58 fallopian tube carcinoma 58 lymphocytosis 58 relapsed ovarian cancer 58 malignant lesions 58 neuroendocrine cancers 58 lobular carcinoma 58 hamartomas 58 Cell Lung Cancer 58 pulmonary metastases 58 cholangiocarcinoma 58 Trichomonas vaginalis 58 peritoneal cancer 58 Hashimoto thyroiditis 58 seminoma 58 LSIL 58 Thyroid nodules 58 Carcinoma 58 supratentorial 58 carcinoid tumors 57 nodular melanoma 57 hepatocellular cancer 57 colorectal cancers 57 mTOR inhibitors 57 situ LCIS 57 cervical carcinoma 57 neoplasm 57 epithelial tumors 57 retroperitoneal 57 HRPC 57 carcinoid tumor 57 heavily pretreated 57 vulvar cancers 57 Cholangiocarcinoma 57 breast carcinomas 57 renal carcinoma 57 cutaneous melanoma 57 Heavy menstrual bleeding 57 node metastases 57 Reversible Posterior Leukoencephalopathy Syndrome 57 PARP inhibition 57 adjuvant radiotherapy 57 atypical fractures 57 liver metastasis 57 endometrial 57 metastatic malignant melanoma 57 intravenous bisphosphonates 57 metastatic lesions 57 invasive lobular carcinoma 57 colorectal neoplasms 57 HCV infection 57 PFO closure 57 hypercalcemia 57 invasive ductal 57 hereditary breast cancer 57 malignant neoplasms 57 B7 H3 57 oncogenic HPV types 57 Adenocarcinoma 57 adrenalectomy 57 thymoma 57 papillary carcinoma 57 malignant ovarian 57 adenocarcinoma 57 microbleeds 57 venous thromboembolism 57 HER2 positive 57 ductal cancer 57 metastatic prostate 57 sarcomas 57 lymph node involvement 57 Metastatic breast cancer 57 DCIS lesions 57 CaP 57 KRAS status 57 GnRH agonists 57 molecular subtypes 57 sarcomatoid 57 intraepithelial neoplasia 57 Adenomas 57 Papillary 57 choriocarcinoma 57 squamous cell carcinoma SCC 57 prostate cancers 57 malignant growths 57 severe hypersensitivity reactions 57 advanced adenomas 57 cancerous enlargement 57 metastases 57 renal cell carcinomas 57 colorectal carcinoma 57 precursor lesions 57 myeloproliferative diseases 57 systemic lupus erythematosus SLE 57 pancreatic islet cell 57 thrombotic events 57 vulvodynia 57 abnormal pap smears 57 adenoma 57 Hepatocellular Carcinoma HCC 57 HER2 overexpression 57 DCIS 57 biochemical recurrence 57 epithelial ovarian 57 Myelodysplastic syndromes MDS 57 gastric cardia 57 transurethral resection 56 circulating EPCs 56 tumor subtypes 56 cell carcinoma 56 Endometrial 56 leiomyosarcoma 56 axillary nodes 56 atypical ductal hyperplasia 56 ovarian cancers 56 differentiated thyroid 56 endometrioid 56 invasive cervical cancer 56 hepatocellular carcinoma 56 Venous thromboembolism 56 ovarian tumors 56 rebleeding 56 chronic prostatitis 56 serous ovarian cancer 56 LHRH receptor positive 56 clinicopathologic 56 HER2 positive cancers 56 colorectal adenocarcinoma 56 tunica vaginalis 56 adjuvant radiation 56 neoadjuvant 56 pCR 56 lymph node metastases 56 GIST tumors 56 RPLS 56 EUS FNA 56 infiltrating ductal carcinoma 56 Endometrial cancer 56 lipomas 56 carotid stenosis 56 squamous cell cancers 56 meningiomas 56 HNSCC 56 papillary renal cell carcinoma 56 Digital Mammographic Imaging 56 mammographic density 56 squamous cell carcinomas 56 prophylactic mastectomy 56 spontaneous regression 56 Phase #/#a trial 56 PNET 56 NMIBC 56 Meningiomas 56 Cristofanilli 56 acute leukemias 56 endophthalmitis 56 Ductal carcinoma 56 Benign Prostatic Hyperplasia BPH 56 NeuroStar TMS Therapy 56 anterior uveitis 56 intestinal metaplasia 56 neoplasias 56 cervical adenocarcinoma 56 mammographically 56 NATRECOR ® 56 Pseudomonas aeruginosa infections 56 contralateral breast cancer 56 neoadjuvant treatment 56 sentinel lymph node biopsy 56 benign growths 56 pelvic malignancies 56 thromboembolism 56 recurrent ovarian 56 CMV disease 56 BRCA2 mutations 56 posaconazole 56 nonalcoholic steatohepatitis NASH 56 localized renal 56 histologic examination 56 Kaposi sarcoma 56 VTE 56 molecular abnormalities 56 lung cancers 56 multicentric 56 colorectal cancer 56 LHRH agonists 56 situ DCIS 56 hematuria 56 benign proliferative breast 56 advanced adenoma 56 atherothrombosis 56 ependymomas 56 germline mutations 56 JMML 56 SCCHN 56 subgroup analyzes 56 K ras mutations 56 histological subtype 56 pleural mesothelioma 56 superficial bladder cancer 56 alveolar soft 56 vaginal cancers 56 Merkel cell carcinoma 56 myeloproliferative disorders 56 sonographically 56 thyroid carcinoma 56 benign breast 56 polycythemia vera 55 CYT# potent vascular disrupting 55 EBRT 55 ovarian hyperstimulation syndrome OHSS 55 lichen planus 55 soft tissue sarcomas 55 nodal metastases 55 Barrett esophagus 55 pancreatic prostate 55 osteochondroma 55 Renal Cell Carcinoma RCC 55 gastric carcinoma 55 squamous cell lung cancer 55 microscopic hematuria 55 papillary thyroid carcinoma 55 Onychomycosis 55 BRCA2 mutation carriers 55 nephron sparing surgery 55 imatinib resistance 55 MGd 55 gynecological cancers 55 schwannomas 55 ovarian cancer 55 radical nephrectomy 55 Zolinza 55 PAOD 55 heterozygous FH 55 Metastatic 55 superinfection 55 sentinel node biopsy 55 invasive ductal carcinoma 55 androgen deficiency 55 basal cell 55 BRCA carriers 55 osteoid osteoma 55 invasive candidiasis 55 invasive coronary angiography 55 gallstone disease 55 preventive mastectomies 55 neurofibromas 55 transitional cell carcinoma 55 generalized vitiligo 55 Candida infection 55 distant metastases 55 pT2 55 ovarian carcinoma 55 liver metastases 55 allogeneic HSCT 55 hypertrophic scars 55 Acute lymphoblastic leukemia 55 leukaemias 55 ToGA 55 HER2 positivity 55 AA Amyloidosis 55 excisional biopsy 55 POAG 55 metastatic disease 55 liver resection 55 perioperative complications 55 invasive bladder 55 colorectal gastric 55 carotid stenting 55 subclinical hypothyroidism 55 lymphoproliferative disorders 55 breast cancers 55 leiomyoma 55 fibroadenomas 55 histologic subtype 55 lymphadenectomy 55 MRgFUS 55 squamous cell 55 pancreatic neuroendocrine tumors 55 thoracic aortic aneurysm 55 HCV infections 55 axillary lymph nodes 55 hepatectomy 55 cystectomy 55 lymphadenopathy 55 Basal cell carcinoma 55 candidemia 55 HER2 amplified 55 brain metastases 55 Acute Myocardial Infarction AMI 55 osteoporotic vertebral fractures 55 Rheumatologists 55 fibrocystic changes 55 gynecologic cancer 55 prolonged QT interval 55 ductal breast cancer 55 Prostatitis 55 ductal adenocarcinoma 55 osteoporotic fractures 55 leukoencephalopathy 55 adenomatous 55 ocular toxicity 55 pericardial effusion 55 HBeAg negative 55 Acute myeloid leukemia 55 androgenetic alopecia 55 BRCA mutations 55 biliary tract cancer 55 osteonecrosis 55 heavy menstrual bleeding 55 infective endocarditis 55 intraoperative complications 55 FGFR2 55 malignant tumors 55 MALT lymphoma 55 Helicobacter pylori infection 55 colon cancers 55 microRNA expression 55 cervical intraepithelial neoplasia 55 gynecologic cancers 55 lobular carcinomas 55 myelofibrosis polycythemia vera 55 metastatic lesion 55 testicular germ cell 55 recurrent glioma 55 total thyroidectomy 55 pituitary adenomas 55 elevated CRP 55 neuroendocrine carcinoma 55 Anal cancer 55 lung cancer NSCLC 55 invasive lobular 55 BRCA mutation carriers 55 BRCA1 mutation carriers 55 chronic GVHD 55 osteoporotic vertebral compression fractures 55 intraductal 55 endoleaks 55 vertebral fracture 55 hyperplastic 55 cervical lesions 55 core needle biopsy 55 recurrent NSCLC 55 symptomatic BPH 55 dysplastic nevi 55 abnormal uterine bleeding 55 malignant ascites 55 gastrointestinal stromal tumors 55 adjuvant therapy 55 abdominal hysterectomy 55 NSCLC 55 atherothrombotic disease 55 premalignant 55 myeloproliferative disorder 55 prostatic adenocarcinoma 55 metastatic malignant 55 Uveitis 55 histologic 55 vandetanib 55 carcinoid cancer 55 gastric cancers 55 paraganglioma 54 vaginal atrophy 54 CTCL 54 DVT PE 54 carotid artery stenting 54 esophageal cancers 54 hamartoma 54 Doxil ® 54 recurrent metastatic 54 Pemetrexed 54 grade gliomas 54 varicella infection 54 renal pelvis 54 cytoreductive surgery 54 endoscopic ultrasonography 54 invasive aspergillosis 54 Pivotal Clinical Trial 54 treat benign prostatic 54 intracranial aneurysms 54 T1c 54 HPV subtypes 54 thyroid cancers 54 congenital anomalies 54 tumoral 54 axillary node 54 Glioma 54 contralateral breast 54 chemoradiation 54 axitinib 54 prostate cancer PCa 54 Squamous cell 54 EBUS FNA 54 BRCA1 mutations 54 undergone radical prostatectomy 54 sentinel nodes 54 nonmetastatic 54 cervical lymph nodes 54 uterine cancers 54 etiologic 54 preoperative chemotherapy 54 femur fractures 54 Uterine Fibroid Embolization 54 cancers 54 KRAS mutation 54 ICD implantation 54 PROSTVAC ® 54 bendamustine 54 venous thrombosis 54 asymptomatic 54 Fibroid tumors 54 metachronous 54 androgen deprivation 54 recurrent VTE 54 Testicular cancer 54 Hodgkin lymphoma HL 54 breast tumors 54 Gastric cancer 54 prospectively randomized 54 cerebral microbleeds 54 metastatic gastric 54 cryptogenic stroke 54 etiologic agent 54 PROSTVAC TM 54 subtrochanteric 54 dysmenorrhea 54 metastatic renal cell carcinoma 54 lung nodules 54 ovarian malignancy 54 hormone receptor positive 54 parathyroid 54 solar keratosis 54 premalignant lesions 54 testicular tumors 54 abnormal mammograms 54 TEAEs 54 plasma kallikrein 54 thymectomy 54 osteoporotic 54 hemorrhagic complications 54 CIN3 + 54 Myelofibrosis 54 fluoroquinolone resistance 54 painless lump 54 postoperative atrial fibrillation 54 Pelvic Inflammatory Disease 54 urolithiasis 54 cervical breast 54 NSABP 54 Squamous 54 neoplastic 54 thyrotoxicosis 54 Mucositis 54 follicular adenoma 54 QTc prolongation 54 distant metastasis 54 KRAS mutations occur 54 Isolagen Therapy 54 urethral stricture 54 malignant lesion 54 ALT flares 54 benign polyps 54 colorectal adenomas 54 HBV infection 54 repigmentation 54 hormone therapy HT 54 microcalcifications 54 cardioembolic stroke 54 LEUKINE 54 clinicopathological 54 metastatic liver 54 myocardial infarctions 54 ixabepilone 54 microvascular complications 54 varicocele 54 lung pancreatic 54 focal cryoablation 54 chemoradiotherapy 54 prospective multicenter study 54 lymphomas 54 resectable 54 systemic scleroderma 54 adenomas 54 cystic lesions 54 pulmonary nodules 54 melanoma 54 trabectedin 54 LCIS 54 sentinel lymph nodes 54 thyroid tumors 54 esophagogastric junction 54 Bladder cancer 54 HPV 54 pan HDAC inhibitor 54 Inflammatory breast cancer 54 curative resection 54 Fibroids 54 ErbB2 positive 54 Epidemiologic studies 54 MDR tuberculosis 54 diagnostic biomarker 54 metastatic neuroendocrine tumors 54 carotid plaques 54 metastatic prostate cancer 54 calcifications 54 HuMax EGFr 54 pre cancerous lesion 54 acute myeloid 54 nonproliferative 54 thromboses 54 retrospective cohort 54 acute aortic dissection 54 decitabine 54 recurrent miscarriage 54 obscure gastrointestinal bleeding 54 ZACTIMA 54 cartilage defects 54 trochanteric bursitis 54 squamous 54 ONJ 54 lobular cancer 54 LVNC 54 renal cell carcinoma 54 malignant melanoma 54 cancerous lesions 54 PRADAXA 54 VUR 54 TORISEL 54 variceal bleeding 54 lymph node metastasis 54 pancreatic ductal adenocarcinoma 54 intracranial hemorrhage ICH 54 ARVD 54 Neulasta ® 54 underwent resection 54 pediatric acute lymphoblastic 54 benign lesions 54 thromboembolic complications 54 solid organ transplantation 54 narcolepsy cataplexy 54 osteolysis 54 thrombotic complications 54 Neoadjuvant 54 relapsed MM 54 grade cervical dysplasia 54 prostate TURP 54 fragility fractures 54 Renal cell carcinoma 54 gastrointestinal stromal tumors GIST 54 ganetespib 54 Octreolin 54 prostate carcinoma 54 CIN3 54 HPV infections 54 cytoreduction 54 Carcinoid tumors 54 WT1 54 recurrent malignant glioma 54 rFVIIa 54 fibrocystic 54 basal cell nevus syndrome 54 elacytarabine 54 tumor lysis syndrome 54 seminomas 54 pancreatic NET 54 dysplastic 54 uterine fibroids 54 transfusion syndrome 54 premenopausal women 53 pre menopausal 53 B Cell Lymphoma 53 prostate cancer CRPC 53 lasofoxifene 53 endometrial cancer 53 androgen independent 53 axilla 53 SEER database 53 TTTS 53 Gliomas 53 precancerous condition 53 sCJD 53 NOMID 53 gonococcal infections 53 KRAS wild 53 breast endometrial 53 cutaneous squamous cell carcinoma 53 bronchogenic carcinoma 53 medically inoperable 53 virtual colonography 53 polycythemia vera PV 53 Embozene TM Microspheres 53 MAGE A3 ASCI 53 DXA scan 53 chromosomal rearrangement 53 TMPRSS2 ERG 53 thyroid nodule 53 Hurthle cell 53 bladder prostate 53 Peyronie 53 pelvic lymph node dissection 53 platinum refractory 53 recurrent glioblastoma 53 Sezary syndrome 53 locoregional 53 pleural effusions 53 perioperative mortality 53 hormone receptor negative 53 basal cell carcinoma 53 metastatic carcinoma 53 squamous cell skin 53 INC# 53 sporadic ALS 53 Toxicities 53 herpes zoster 53 teratoma 53 lymph node dissection 53 Chronic lymphocytic leukemia 53 psoriatic 53 ano genital warts 53 bacteriuria 53 hormone refractory 53 malignant prostate 53 Paget disease 53 lymphatic mapping 53 astrocytomas 53 castration resistant prostate cancer 53 BRAF V#E 53 anaplastic 53 biologic DMARD 53 hematopoietic malignancies 53 alvespimycin 53 BRAF mutation 53 polycythemia vera essential thrombocythemia 53 cholelithiasis 53 extracranial 53 ultrasonographic 53 refractory ovarian cancer 53 Cell Lymphoma 53 sarcoma 53 myomas 53 Lyme arthritis 53 Human papillomavirus 53 esophageal adenocarcinoma 53 HRCT 53 LQTS 53 basal cell cancers 53 neovascular AMD 53 renal artery stenosis 53 taxane therapy 53 Radical prostatectomy 53 radical prostatectomy RP 53 Wegener granulomatosis 53 situ CIS 53 pelvic lymphadenectomy 53 symptomatic fibroids 53 hyperplasia BPH 53 LUTS 53 leukemia AML 53 synovial sarcoma 53 pancreatic carcinoma 53 diabetes mellitus DM 53 HPV infection 53 angiogenesis inhibitor 53 heart valve insufficiency 53 IV melanoma 53 lung metastasis 53 recurrent GBM 53 pre cancerous lesions 53 definite stent thrombosis 53 prophylactic mastectomies 53 hyperparathyroidism 53 papillary thyroid cancer 53 cell lymphomas 53 necrotizing 53 Erlotinib 53 Soft Tissue Sarcoma 53 Azedra 53 CMV infection 53 T2DM 53 metastatic cancer 53 HSDD 53 malignant lymphoma 53 HPV genotypes 53 non squamous NSCLC 53 atherothrombotic 53 lymph node removal 53 appendiceal 53 contralateral prophylactic mastectomy 53 chemoresistant 53 pain palliation 53 prostate biopsies 53 thoracic aortic disease 53 endometriosis 53 Glioblastoma Multiforme 53 bisphosphonate therapy 53 eosinophilic pneumonia 53 HER2 expression 53 ductal lavage 53 periprocedural MI 53 meningioma 53 BCCs 53 acute phosphate nephropathy 53 nephrectomy 53 Acute myeloid leukemia AML 53 bacterial vaginosis BV 53 CIMZIA ™ 53 lipid abnormalities 53 Chlamydia trachomatis infection 53 hematopoietic cell 53 giant cell arteritis 53 benign prostatic hypertrophy 53 invasive fungal infection 53 dysplasia 53 colectomy 53 mCRC patients 53 esophageal squamous cell carcinoma 53 secondary hyperparathyroidism 53 histological subtypes 53 relapsed SCLC 53 precancerous cervical 53 trabedersen 53 radical retropubic prostatectomy 53 adnexal mass 53 mycophenolate mofetil 53 colorectal 53 randomized Phase III 53 cervical vulvar 53 oophorectomy 53 HPV# 53 postoperative mortality 53 NP CRNs 53 follicular lymphoma 53 hepatologists 53 rectal carcinoma 53 surgical biopsies 53 monoclonal gammopathy 53 nephrogenic systemic fibrosis 53 intravesical therapy 53 Screening Trial DMIST 53 metastatic colorectal 53 kidney urologic 53 ovarian breast 53 vWD 53 pathologic 53 castrate resistant prostate cancer 53 vascular lesion 53 histologic subtypes 53 sonographic appearance 53 endometrial tumors 53 nasopharyngeal cancer 53 thrombophilia 53 pulmonary hypertension PH 53 lung adenocarcinoma 53 allograft rejection 53 SIR Spheres 53 grade squamous intraepithelial 53 gastrointestinal malignancies 53 Botox botulinum toxin 53 gastrointestinal stromal tumor GIST 53 peritoneal carcinomatosis 53 Chronic Lymphocytic Leukemia CLL 53 Gorlin syndrome 53 rectal cancers 53 stenoses 53 DCVax R 53 ovarian lung 53 melanomas 53 TACI Ig 53 superficial basal cell carcinoma 53 grade glioma 53 AML MDS 53 thromboembolic 53 histopathologic examination 53 ALK mutations 53 chondrosarcoma 53 Xanafide 53 Chronic HCV 53 PHPT 53 FSGS 53 Severe Primary IGFD 53 benign neoplasms 53 OMAPRO 53 lobular breast cancer 53 Hereditary angioedema HAE 53 fetal chromosomal 53 ICD implants 53 BCG refractory 53 pathologic fractures 53 tivozanib 53 hypermethylation 53 carotid plaque 53 somatic mutation 53 CA4P 53 Ectopic pregnancy 53 vesicoureteral reflux 53 NSCLC tumors 53 histopathologic findings 53 aHUS 53 HER2 positive metastatic breast 53 Ophena TM 53 huC# DM4 53 capsular contracture 53 ductal 53 Tardive dyskinesia 53 progressive multifocal leukoencephalopathy PML 53 aortic regurgitation 53 ependymoma 53 paroxysmal AF 53 keloid 53 Anaplastic 53 Glioblastoma 53 familial ALS 53 anaplastic thyroid cancer 53 ankylosing spondylitis AS 53 hypervascular tumors 53 chronic HBV infection 53 SIR Spheres microspheres 53 Cutaneous T 53 HoFH 53 aseptic meningitis 53 transthyretin amyloidosis 53 Sipuleucel T 53 pre malignant lesions 53 Sjögren syndrome 53 stage IIIB 53 gadolinium enhanced 53 ccRCC 53 carotid endarterectomy CEA 53 pancreatic cancers 53 Pulmonary embolism 53 pulmonary emboli 53 fallopian tube cancers 53 histologically 53 Medullary thyroid cancer 53 untreated celiac disease 53 lupus nephritis 53 vestibular schwannomas 53 B CLL 53 bowel cancers 53 acute PAO 52 thyroidectomy 52 Pancreatic neuroendocrine tumors 52 aortic dissections 52 histologies 52 Endometrial Cancer 52 systemic lupus erythematosus 52 uterus fallopian tubes 52 ExTRACT TIMI 52 prostate cancer AIPC 52 bisphosphonate 52 pleomorphic 52 EGFR HER2 52 hydronephrosis 52 grade dysplasia 52 metaplasia 52 lacunar 52 EGFR mutations 52 Hypotension 52 Embolization 52 gynecologic malignancy 52 mammary cancers 52 bone metastases 52 neuroblastomas 52 metastatic melanoma 52 HCV antibody 52 cardiac toxicity 52 metastatic bladder 52 mutated BRAF gene 52 physiologic mechanisms 52 clinically insignificant 52 HER2 positive tumors 52 extramedullary 52 EORTC 52 ZD# [001] 52 resected tumors 52 juvenile idiopathic arthritis 52 Metastases 52 genital sores 52 dutasteride 52 VATS lobectomy 52 corneal ectasia 52 oncologic outcomes 52 Bezielle 52 pathologic diagnosis 52 ENDEAVOR IV 52 Diabetic nephropathy 52 macroalbuminuria 52 liver transplant recipients 52 STRIDE PD 52 fine needle aspiration 52 GPC5 52 vismodegib 52 ductal carcinoma 52 duplex ultrasonography 52 cancerdefine 52 carcinoids 52 relapsed refractory 52 adjuvant chemotherapy 52 NPM1 52 lymphovascular invasion 52 chronic pelvic 52 echogenic